{"title":"[Effect of Dengzhan Xxin Injection Dosage on Renal function Using Propensity Score Estimation].","authors":"Yuan-Yuan Li, Hao Tang, Lin Li, Yan-Ming Xie","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Objective To observe clinical dose of Dengzhan Xixin Injection (DZI) on renal func- tion and analyze its relation with abnormal changes of renal function indices [serum creatinine (SCr) and blood urea nitrogen (BUN) ]. Methods The information of 21 498 patients who used DZI were recruited from 20 hospital information system (HIS) database across China. Of them, 13 696 patients in line with 18 -80 years old were taken as subjects. They were assigned to the ultra-dose group ( >40 mL) and the conventional dose group ( ≤40 mL) according to whether the single DZI dosage exceeded the recommended dosage in the drug instruction. Changes of SCr and BUN were taken as outcome evaluation indicators 7 days before and after administration of DZI. There were 650 cases with two SCr values, 87 in the ultra-dose group and 563 in the conventional dose group. There were 651 cases with two BUN values, 87 in the ultra-dose group and 564 in the conventional dose group. Data were analyzed using stratified analysis and propensity score estimation. Results No statistical difference existed in age, gender, admission condi- tion, or stratification estimation results of DZI course between the ultra-dose group. and t6e conventional dose group (P >0. 05). No statistical difference existed in changes of abnormal renal functions between the ultra-dose group and the conventional dose group after balancing 71 confounders factors by propensity score estimation (P >0. 05). Conclusion Analyzed based on HIS data, use of DZI exceeding recommended dosage did not result in abnormal changes of renal function.</p>","PeriodicalId":10107,"journal":{"name":"中国中西医结合杂志","volume":"36 12","pages":"1430-1434"},"PeriodicalIF":0.0000,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国中西医结合杂志","FirstCategoryId":"3","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective To observe clinical dose of Dengzhan Xixin Injection (DZI) on renal func- tion and analyze its relation with abnormal changes of renal function indices [serum creatinine (SCr) and blood urea nitrogen (BUN) ]. Methods The information of 21 498 patients who used DZI were recruited from 20 hospital information system (HIS) database across China. Of them, 13 696 patients in line with 18 -80 years old were taken as subjects. They were assigned to the ultra-dose group ( >40 mL) and the conventional dose group ( ≤40 mL) according to whether the single DZI dosage exceeded the recommended dosage in the drug instruction. Changes of SCr and BUN were taken as outcome evaluation indicators 7 days before and after administration of DZI. There were 650 cases with two SCr values, 87 in the ultra-dose group and 563 in the conventional dose group. There were 651 cases with two BUN values, 87 in the ultra-dose group and 564 in the conventional dose group. Data were analyzed using stratified analysis and propensity score estimation. Results No statistical difference existed in age, gender, admission condi- tion, or stratification estimation results of DZI course between the ultra-dose group. and t6e conventional dose group (P >0. 05). No statistical difference existed in changes of abnormal renal functions between the ultra-dose group and the conventional dose group after balancing 71 confounders factors by propensity score estimation (P >0. 05). Conclusion Analyzed based on HIS data, use of DZI exceeding recommended dosage did not result in abnormal changes of renal function.